This site is intended for Healthcare Professionals only.

PhAS 2022: 1,445 pharmacies are now eligible

Date:

Share post:

The Department of Health and Social Care has updated the list of community pharmacies eligible for the Pharmacy Access Scheme (PhAS) and approved 43 cases out of 63 applications, bringing the the total number of eligible pharmacies in England to 1,445.

Earlier this year, NHS England and NHS Improvement (NHSE&I) invited community pharmacy contractors to apply for a review if they believed there were any inaccuracies in relation to pharmacy premises addresses or unforeseen circumstances affecting access, such as a permanent roadblock.

Submitted applications were reviewed by the relevant NHSE&I regional pharmacy contract team, and determined by the relevant pharmaceutical services regulations committees (PSRC).

Due to the workload pressures seen over winter, the review deadline was extended, giving contractors applying for a review two full months to complete their applications. This also pushed back the announcement of the outcome of the review, but where an application has been successful, PhAS payments will be backdated to the start of the scheme.

The full list of pharmacies eligible for the 2022 PhAS can be found here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Layla Moran elected Chair of Health and Social Care Committee

The Liberal Democrat MP emphasises the importance of finding common ground across political lines to address key issues...

Pharmacist Support launches dual-focused fundraising campaign

As Remember a Charity Week begins, Pharmacist Support is encouraging supporters to consider leaving a gift in their...

Extra appointments ‘not enough’ to solve NHS waiting list crisis – new analysis reveals

The government’s extra two million appointments a year would only address about 15% of the additional activity required...

Potential Side Effects of Mounjaro [What You Need to Know]

In recent years, Mounjaro, a medication used for managing Type 2 diabetes, has gained significant attention due to...